Fielmann (FIE) AI Stock Analysis

• Market Cap: €4.62B
• Dividend Yield: 2.09%
• Average Volume (3M): 37.52K
• Price to Earnings (P/E): 30.4
• Beta (1Y): 0.75
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: DE
• Employees: 20,221
• Sector: Services
• Sector Strength: N/A
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.62
• Shares Outstanding: 84,000,000
• 10 Day Avg. Volume: 32,183
• 30 Day Avg. Volume: 37,517
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €64.33
• Price Target Upside: 16.96% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 4

• Rating: 74 Outperform
• Price Target: €62.00 ▲(12.73% Upside)

Fielmann's stock score reflects strong financial performance and positive technical indicators, driven by solid revenue growth, profitability, and upward price momentum. However, the high P/E ratio suggests potential overvaluation, and technical indicators warn of possible overbought conditions. Investors should monitor leverage and valuation risks.

Fielmann Business Overview & Revenue Model

Company Description

Fielmann AG is a leading optical retail company based in Germany, specializing in the sale of eyewear, including glasses, contact lenses, and sunglasses. With a strong presence in the European market, Fielmann operates a vast network of stores, offering a range of optical products and services. The company is known for its commitment to quality, customer service, and competitive pricing in the eyewear sector.

How the Company Makes Money

Fielmann generates revenue primarily through the sale of eyewear products, including prescription glasses, sunglasses, and contact lenses. The company operates a retail model, where customers can purchase products directly from their stores or online. Additionally, Fielmann offers eye examinations and optical services, which also contribute to its revenue. The company benefits from a strong brand reputation and customer loyalty, leading to repeat business. Key revenue streams include direct product sales, service fees from eye exams, and partnerships with various lens and frame manufacturers, which may provide discounts or incentives for Fielmann to sell their products. The company's extensive store network and e-commerce platform further enhance its reach and sales potential.

Fielmann Financial Statement Overview

Summary

Fielmann exhibits a solid financial performance with consistent revenue growth and strong profitability metrics. The balance sheet maintains a healthy equity position despite increased leverage, and cash flow remains robust, supporting capital expenditures. Overall, Fielmann is on a positive financial trajectory with some leverage-related risks to monitor.

Income Statement

Fielmann has demonstrated consistent revenue growth over the years, with a notable increase from 2019 to 2024. The gross profit margin is strong, consistently above 75%, indicating efficient cost management. The net profit margin and EBIT margin have shown positive trends, reflecting profitability improvements. However, the EBITDA margin and net income growth have been more volatile, suggesting some fluctuations in operational efficiency.

Balance Sheet

The balance sheet reveals a healthy equity position, with the equity ratio improving over time. The debt-to-equity ratio has increased, signaling higher leverage, but remains within manageable levels. Return on Equity (ROE) has shown a positive trajectory, indicating effective use of equity to generate profits. Despite the increased debt, the overall stability of the balance sheet is maintained.

Cash Flow

Fielmann's cash flow statements show robust operating cash flow, consistently covering capital expenditures. The free cash flow has grown steadily, enhancing liquidity. The operating cash flow to net income ratio suggests strong cash generation relative to profitability. However, a notable capital expenditure in recent years indicates significant reinvestment in the business, which could impact immediate cash reserves.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.72B	2.26B	1.97B	1.76B	1.68B	1.43B
Gross Profit	1.39B	1.81B	1.57B	1.38B	1.34B	1.15B
EBITDA	318.86M	475.73M	403.80M	346.99M	389.78M	328.70M
Net Income	122.63M	152.11M	127.64M	103.66M	136.85M	116.41M
Balance Sheet
Total Assets	0.00	2.37B	1.99B	1.77B	1.74B	1.67B
Cash, Cash Equivalents and Short-Term Investments	101.68M	101.68M	81.83M	149.87M	235.54M	221.24M
Total Debt	0.00	873.85M	592.15M	505.66M	458.26M	425.72M
Total Liabilities	-913.14M	1.46B	1.06B	909.10M	863.09M	832.86M
Stockholders Equity	913.14M	899.13M	867.65M	804.22M	819.83M	779.20M
Cash Flow
Free Cash Flow	0.00	327.41M	196.00M	182.69M	260.15M	188.40M
Operating Cash Flow	0.00	410.09M	282.79M	268.08M	346.69M	278.47M
Investing Cash Flow	0.00	-331.17M	-143.25M	-159.85M	-74.85M	-219.67M
Financing Cash Flow	0.00	-44.27M	-112.57M	-232.33M	-201.22M	-85.42M

Fielmann Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 55.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:FIE, the sentiment is Neutral. The current price of 55 is below the 20-day moving average (MA) of 55.75, below the 50-day MA of 55.08, and above the 200-day MA of 46.40, indicating a neutral trend. The MACD of -0.10 indicates Positive momentum. The RSI at 43.96 is Neutral, neither overbought nor oversold. The STOCH value of 27.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DE:FIE.

Fielmann Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FIE	74 Outperform	€4.62B	30.37		2.09%	―	―
Sector *	66 Neutral	€7.34B	13.03	35.20%	3.67%	2.10%	-119.61%
AFX	60 Neutral	€3.94B	24.90	7.48%	1.36%	5.21%	-39.36%